Hunan Er-Kang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. It offers pharmaceutical excipients, active pharmaceutical ingredients (API) and pharmaceutical preparation. The pharmaceutical excipients produce glycerol, medicinal alcohol, propylene glycol, medicinal sodium hydroxide and medical sucrose. The API includes glycerol, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium and calamine powder. The pharmaceutical preparation provides sulbenicillin sodium injection and compound liquorice tablets. The company was founded by Fang Wen Shuai on October 22, 2003 and is headquartered in Changsha, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company